Codexis Accounts Receivable:
7.412M for Dec. 31, 2012Codexis Historical Accounts Receivable Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 7.412M |
| Dec. 31, 2012 | 7.545M |
| Sept. 30, 2012 | 16.53M |
| June 30, 2012 | 8.124M |
| March 31, 2012 | 18.55M |
| Dec. 31, 2011 | 18.92M |
| Sept. 30, 2011 | 19.32M |
| June 30, 2011 | 11.31M |
| March 31, 2011 | 11.32M |
| Dec. 31, 2010 | 15.33M |
| Sept. 30, 2010 | 15.38M |
| June 30, 2010 | 7.289M |
| March 31, 2010 | 6.561M |
| Dec. 31, 2009 | 7.246M |
| Sept. 30, 2009 | 7.037M |
| Dec. 31, 2008 | 6.193M |
| March 31, 2008 | Go Pro |
About Accounts Receivable
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
YCharts takes accounts receivable from the balance sheet of a company. It is reported net of allowance for bad debts.
Learn More
CDXS Accounts Receivable Benchmarks
| Companies | |
|---|---|
| Albany Molecular Research | 42.50M |
| Exelixis | |
| ARCA biopharma |
CDXS Accounts Receivable Rankings
| Overall |
63rd percentile 2801 of 7590 |
| Sector |
60th percentile 258 of 651 in Healthcare |
| Industry |
79th percentile 48 of 238 in Biotechnology |
CDXS Accounts Receivable Range, Past 5 Years
| Minimum | 6.193M | Dec 2008 |
| Maximum | 19.32M | Sep 2011 |
| Average | 11.50M |
